Ratings by Goldman Sachs (Patrick Donnelly)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2019 | Bio-Rad Labs | BIO | Upgrade | Conviction Buy (Buy) |
330.95 (364.26) |
10.06% | Details | |
| 8/14/2019 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Neutral (N/A) |
|
Details | ||
| 7/22/2019 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Neutral (N/A) |
38.01 (25.49) |
-32.94% | Details | |
| 7/15/2019 | Bruker | BRKR | Upgrade | Neutral (Sell) |
49.85 (58.65) |
17.65% | Details | |
| 7/15/2019 | Quest Diagnostics | DGX | Downgrade | Sell (Neutral) |
103.50 (241.76) |
133.58% | Details | |
| 6/11/2019 | Avantor Inc. | AVTR | New Coverage | Buy (N/A) |
17.20 (13.96) |
-18.84% | Details | |
| 4/12/2019 | Exact Sciences | EXAS | Upgrade | Conviction Buy (Buy) |
95.15 (104.91) |
10.26% | Details | |
| 4/9/2019 | PerkinElmer | PKI | Upgrade | Conviction Buy (Neutral) |
99.00 (115.24) |
16.4% | Details | |
| 2/26/2019 | Exact Sciences | EXAS | Upgrade | Buy (Neutral) |
92.04 (95.15) |
3.38% | Details | |
| 1/30/2019 | Illumina | ILMN | Maintain | Neutral (Neutral) |
|
Details | ||
| 1/8/2019 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/30/2018 | T2 Biosystems, Inc | TTOO | Maintain | Neutral (N/A) |
|
Details | ||
| 11/30/2018 | Bio-Techne Corp. | TECH | Maintain | Neutral (N/A) |
|
Details | ||
| 11/30/2018 | Bio-Rad Labs | BIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2018 | Laboratory Corporation of America | LH | Downgrade | Buy (Conviction Buy) |
165.09 (330.44) |
100.16% | Details | |
| 11/30/2018 | Myriad Genetics | MYGN | Upgrade | Neutral (Sell) |
31.44 (3.19) |
-89.85% | Details | |
| 11/30/2018 | Waters Corp. | WAT | Downgrade | Sell (Neutral) |
202.22 (415.84) |
105.64% | Details | |
| 11/30/2018 | Quest Diagnostics | DGX | Downgrade | Neutral (Buy) |
96.93 (103.50) |
6.78% | Details | |
| 10/17/2018 | Bio-Rad Labs | BIO | New Coverage | Buy (N/A) |
277.78 (330.95) |
19.14% | Details | |
| 10/17/2018 | Bio-Techne Corp. | TECH | New Coverage | Neutral (N/A) |
182.19 (72.48) |
-60.22% | Details | |
| 9/17/2018 | Thermo Fisher Scientific | TMO | Downgrade | Neutral (Conviction Buy) |
243.83 (613.54) |
151.63% | Details | |
| 9/17/2018 | Agilent | A | Upgrade | Conviction Buy (Buy) |
69.33 (155.41) |
124.16% | Details | |
| 8/30/2018 | Exact Sciences | EXAS | Maintain | Neutral (Neutral) |
|
Details |
